Speaker Profile

Ph.D., Associate Research Scientist, Epidemiology of Microbial Diseases, Yale School of Public Health

Biography
Early in the COVID-19 pandemic, Dr. Wyllie joined the Yale IMPACT (Implementing Medical and Public health Action against Coronavirus, CT) team to co-lead the virology section, responsible for the detection of SARS-CoV-2 in saliva and other COVID-19 patient specimen sources as well as in an asymptomatic healthcare worker cohort. Having worked with saliva as a clinical specimen for pneumococcal carriage detection for almost 10 years, Dr. Wyllie is an expert in the laboratory methods required for working with saliva and skillfully applied these for SARS-CoV-2 detection. The use of saliva as an alternative sample type can alleviate many of the bottlenecks encountered in the mass testing strategies required to control continuing outbreaks. In an effort to address many of these issues, Wyllie further validated and optimized saliva for SARS-CoV-2 detection and together with Nathan Grubaugh developed SalivaDirect: a simple, scalable and importantly, cost-effective method to help alleviate SARS-CoV-2 testing demands.


×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by AUG. 1ST

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required